Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

STRATA Skin Sciences (SSKN) EBIAT (2016 - 2025)

STRATA Skin Sciences' EBIAT history spans 14 years, with the latest figure at $58000.0 for Q4 2025.

  • On a quarterly basis, EBIAT rose 101.27% to $58000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$6.3 million, a 37.92% increase, with the full-year FY2025 number at -$6.3 million, up 37.92% from a year prior.
  • EBIAT hit $58000.0 in Q4 2025 for STRATA Skin Sciences, up from -$1.6 million in the prior quarter.
  • Over the last five years, EBIAT for SSKN hit a ceiling of $1.1 million in Q2 2021 and a floor of -$4.6 million in Q4 2024.
  • Historically, EBIAT has averaged -$1.8 million across 5 years, with a median of -$2.0 million in 2022.
  • Biggest five-year swings in EBIAT: surged 164.4% in 2021 and later crashed 2729.67% in 2025.
  • Tracing SSKN's EBIAT over 5 years: stood at -$849000.0 in 2021, then soared by 81.15% to -$160000.0 in 2022, then crashed by 2271.25% to -$3.8 million in 2023, then dropped by 20.06% to -$4.6 million in 2024, then surged by 101.27% to $58000.0 in 2025.
  • Business Quant data shows EBIAT for SSKN at $58000.0 in Q4 2025, -$1.6 million in Q3 2025, and -$2.6 million in Q2 2025.